GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Κατάταξη σε μετοχές
#3670
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Τιμή μετοχής
$27.08
Κεφαλαιοποίηση
$4.59B
Αλλαγή (1 ημέρα)
-1.68%
Αλλαγή (1 έτος)
-13.61%
Χώρα
IN
Εμπόριο GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Κατηγορία
Healthcare
Δείκτης P/S για GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Δείκτης P/S στις October 2026 TTM: 10.72
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της GlaxoSmithKline Pharmaceuticals Limited, ο τρέχων δείκτης P/S (TTM) είναι 10.72. Στο τέλος του 2024, ο δείκτης ήταν 9.74.
Ιστορικό P/S για την GlaxoSmithKline Pharmaceuticals Limited από 2004 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 10.72 | -15.16% |
| 2025 | 12.64 | 29.73% |
| 2024 | 9.74 | 41.17% |
| 2023 | 6.90 | -19.88% |
| 2022 | 8.61 | 3.26% |
| 2021 | 8.34 | 26.28% |
| 2020 | 6.61 | -6.14% |
| 2019 | 7.04 | 13.41% |
| 2018 | 6.21 | -22.36% |
| 2017 | 7.99 | -31.64% |
| 2016 | 11.69 | 6.32% |
| 2015 | 11.00 | 10.60% |
| 2013 | 9.94 | 43.71% |
| 2012 | 6.92 | -0.12% |
| 2011 | 6.93 | -24.74% |
| 2010 | 9.20 | 28.61% |
| 2009 | 7.16 | 24.35% |
| 2008 | 5.76 | 6.38% |
| 2007 | 5.41 | -12.92% |
| 2006 | 6.21 | -1.99% |
| 2005 | 6.34 | 32.89% |
| 2004 | 4.77 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| 14.32 | 33.54% |
US
|
|
| 6.16 | -42.56% |
US
|
|
| 7.78 | -27.45% |
US
|
|
| 5.48 | -48.88% |
US
|
|
| 4.66 | -56.56% |
CH
|
